Agoracom Blog Home

Posts Tagged ‘#TraceAnalytics’

Applied Biosciences #CBD-based Functional Drinks Targeting Health Conscious Consumers $PFE $WMD.ca $CGRW $APH.ca $GBLX $ACG.ca $ACB.ca $WEED.ca $HIP.ca

Posted by AGORACOM at 2:10 PM on Wednesday, July 17th, 2019

SPONSOR: Applied Biosciences Corp. is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics and biopharmaceuticals, as well as state-of-the-art testing and analytics capabilities to our customers.  As a leading company in the CBD, Pet and Health and Wellness space, the company is currently shipping to the majority of US states as well as to 5 International countries. Click Here for More Info

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
APPB : OTC
  • Cannabis-based concentrates, extracts, and edibles are becoming highly popular among consumers
  • Specifically, the edible and beverage marketplace is quickly gaining popularity due to the ease at which customers can use the products

NEW YORK, July 16, 2019 — Each year, more and more countries are moving towards approving cannabis use. In particular, medicinal cannabis is witnessing immense support as most of the countries looking to enter into the market space are more keen on the medical sector due to the therapeutic benefits associated with cannabis. However, several regions around the world have also either decriminalized or legalized the use of recreational cannabis in moderate amounts. For instance, Canada completely legalized adult-use cannabis in late 2018. On the other hand, countries such as Colombia and Spain have only decriminalized recreational use, allowing adults to possess up to a certain amount.

Moreover, the U.S. has given states the jurisdiction to legalize cannabis or keep the drug illicit. As a result, more than half the U.S. legalized cannabis for medical use, while a fifth of the nation, including the District of Columbia, allows for legal recreational usage. While the medical marketplace is much more globally prevalent, the recreational market is expected to overshadow the medical segment as the North American market continues to mature.

Additionally, as the recreational market continues to expand, consumers are also experiencing an influx of new products. Aside from traditional cannabis flower, consumers can now choose from a variety of products at dispensaries and retail stores. Now, cannabis-based concentrates, extracts, and edibles are becoming highly popular among consumers. Specifically, the edible and beverage marketplace is quickly gaining popularity due to the ease at which customers can use the products.

Furthermore, a large recreational user base exists for the edible and beverage market, and the industry is heavily being accelerated by the increasing demand for wellness products to treat a variety of health concerns. According to data compiled by Reports and Data, the global cannabis-based beverage market was valued at USD 1.57 Billion in 2018. By 2026, the market is expected to reach USD 5.04 Billion while exhibiting a CAGR of 15.4% during the forecast period.

The cannabis-infused edible and beverage market is expected to witness a strong increase in demand, particularly for beverages over the next several years. Canaccord Genuity analyst Bobby Burleson noted last year that beverages packed with CBD or THC ingredients can account for nearly 20% of the U.S. edible products markets by 2022, increasing from 6% in 2018. Burleson highlighted that the growing beverage industry is becoming an attractive investment opportunity for beer and soda makers and that data has shown that there is a direct correlation between alcohol and cannabis consumption.

A joint research conducted by the University of Connecticut, Georgia State University, and Universidad Del Pacifico discovered that counties located in medical marijuana states witnessed a 15% reduction in monthly alcohol sales. The conclusion of the study uncovered that cannabis and alcohol are both substitutes for one another, meaning that they share the same target audience. The study also indicates that as more countries move towards cannabis legalization, more users will be inclined to shift over to the cannabis market. The shift has even prompted alcohol producers to enter into the cannabis industry to maximize its consumer base reach.

While alcohol beverage producers may look towards developing THC beverages, soda producers are looking to leverage CBD for health and wellness beverages. Soda producers are specifically focusing on CBD because of the consumer shifts from sugary drinks to more functional options. Regardless of the market type, Canaccord expects both the THC and CBD-based beverage markets in the U.S. to experience growth, as by 2022, Canaccord expects the demand for CBD beverages to reach USD 260 Million, while THC beverages are projected to reach USD 34 Million. “Interest has spiked from the beer industry on mounting evidence of a substitution relationship between cannabis and alcohol, while large soda companies increasingly view CBD as a natural fit within their strategically important wellness offerings,” Burleson wrote.

Read More: https://www.prnewswire.com/news-releases/cbd-based-functional-drinks-charm-health-conscious-consumers-300885358.html

CLIENT FEATURE: $APPB Prior Chief Medical Officer and Senior Director of Oncology Research and Development with Pfizer Inc. appointed APPB CEO $PFE $WMD.ca $CGRW $APH.ca $GBLX $ACG.ca $ACB.ca $WEED.ca $HIP.ca

Posted by AGORACOM at 1:17 PM on Thursday, June 13th, 2019
  • Dr. Raymond  W. Urbanski MD, PhD, will work closely with the Board of Directors to set the vision and strategic direction of the company
  • Will establish organizational structure, processes and key hires necessary to continue the growth of Applied BioSciences. 
  • Overseeing the development of key products in the Applied BioSciences’ product pipeline
  • Directing development within the newly formed Applied BioPharma Division which is focused on innovative cannabinoid therapies being developed to address the unmet medical needs of patients across multiple therapeutic areas.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected] Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp

CLIENT FEATURE: Prior Chief Medical Officer and Senior Director of Oncology Research and Development with Pfizer Inc. appointed APPB CEO $PFE $WMD.ca $CGRW $APH.ca $GBLX $ACG.ca $ACB.ca $WEED.ca $HIP.ca

Posted by AGORACOM at 11:41 AM on Monday, June 3rd, 2019
  • Dr. Raymond  W. Urbanski MD, PhD, will work closely with the Board of Directors to set the vision and strategic direction of the company
  • Will establish organizational structure, processes and key hires necessary to continue the growth of Applied BioSciences. 
  • Overseeing the development of key products in the Applied BioSciences’ product pipeline
  • Directing development within the newly formed Applied BioPharma Division which is focused on innovative cannabinoid therapies being developed to address the unmet medical needs of patients across multiple therapeutic areas.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected] Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp

CLIENT FEATURE: $APPB Prior Chief Medical Officer and Senior Director of Oncology Research and Development with Pfizer Inc. Joins APPB as its CEO $PFE $WMD.ca $CGRW $APH.ca $GBLX $ACG.ca $ACB.ca $WEED.ca $HIP.ca

Posted by AGORACOM at 11:28 AM on Thursday, May 23rd, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Dr. Raymond  W. Urbanski MD, PhD, will work closely with the Board of Directors to set the vision and strategic direction of the company
  • Will establish organizational structure, processes and key hires necessary to continue the growth of Applied BioSciences. 
  • Overseeing the development of key products in the Applied BioSciences’ product pipeline
  • Directing development within the newly formed Applied BioPharma Division which is focused on innovative cannabinoid therapies being developed to address the unmet medical needs of patients across multiple therapeutic areas.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp

Applied Biosciences $APPB Hires Former Pfizer Business Unit Chief Medical Officer as Chief Executive Officer $PFE $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM at 8:42 AM on Tuesday, May 7th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Appointed Dr. Raymond W. Urbanski MD, PhD as its Chief Executive Officer.
  • Former business unit Chief Medical officer and senior director of oncology research and development with Pfizer Inc. (PFE)
  • Dr. Urbanski, will work closely with the Board of Directors, will set the vision and strategic direction of the company putting into place the organizational structure, processes and key hires necessary to continue the growth of Applied BioSciences

LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid-based therapeutics company focused on the medical, biopharmaceutical testing, consumer and veterinary health industries, announced today the appointment of Dr. Raymond  W. Urbanski MD, PhD, the former business unit Chief Medical officer and senior director of oncology research and development with Pfizer Inc. (PFE), as its Chief Executive Officer. 

Dr. Urbanski, will work closely with the Board of Directors, will set the vision and strategic direction of the company putting into place the organizational structure, processes and key hires necessary to continue the growth of Applied BioSciences.  Dr. Urbanski will also oversee the development of key products in the Applied BioSciences’ product pipeline, including assets within the newly formed Applied BioPharma division which is focused on innovative cannabinoid therapies being developed to address the unmet medical needs of patients across multiple therapeutic areas.

Dr. Urbanski joins Applied BioSciences with an impressive list of accomplishments throughout his career ranging from academic research and private practice to his work and rise within the pharmaceutical industry.  Dr. Urbanski spent eight years with Pfizer and held several positions within the company which included medical director of diversified products, senior medical director of breast cancer products, senior medical director of oncology clinical R&D, and eventually Vice President/Chief Medical Officer of the Established Products Business Unit.  In addition to his roles with Pfizer, Dr. Urbanski served as Chief Medical Officer of Mylan Inc., Chief Medical Officer of MannKind Corp., and Senior Director of US Medical Affairs for Aventis.

He brings extensive experience in building highly effective and efficient organizations as well as experience in all phases of drug development across numerous therapeutic areas including hematology/oncology, rheumatology, neurology, cardiovascular medicine, and endocrinology/diabetes. 

“The strengthening of our executive team is a key development at an exciting time for the company enhancing our future growth trajectory,” said Scott Stevens, Founder and Chairman of the Board, “Dr. Urbanski’s big pharma and biotech expertise is well suited to develop the assets and relationships of Applied BioSciences and Applied BioPharma.  He will be instrumental in helping to guide our existing assets and Scientific Advisory board to commercial success. We are excited to have him join our team.”

“Since my days in practice I have been a believer in the cannabinoids.  I always knew that the cannabinoids could be useful agents for the treatment of a whole range of ailments and diseases.  As the science has progressed and some barriers have come down this is the ideal time and environment to make these products and drugs available.  Applied BioSciences is uniquely poised to lead these efforts. “commented Dr. Urbanski.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Applied Biosciences $APPB Retains the Emmes Group to Partner on Therapeutic Development Initiatives $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM at 10:38 AM on Monday, April 8th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Retained the Emmes Group to assist with the development and execution of the Company’s partnership and technology licensing initiatives and strategies.
  • The Company believes that by assembling a well-versed and well-seasoned group of individuals involved in different facets of the medical and scientific business model, the Company will be able to successfully execute and achieve its corporate and therapeutic development goals.

LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and pet health industries, announced that is has retained the Emmes Group to assist with the development and execution of the Company’s partnership and technology licensing initiatives and strategies.

Through this new partnership, Emmes and the Company will work together to formulate a line of medical and scientific focused cannabidiol (“CBD”) based products to target the endocannabinoid system under the “Applied BioPharma” brand.

Applied BioSciences has retained several industry leading individuals as scientific advisory board members and in corporate management consultative capacities. The Company believes that by assembling a well-versed and well-seasoned group of individuals involved in different facets of the medical and scientific business model, the Company will be able to successfully execute and achieve its corporate and therapeutic development goals.

“I am pleased to have the opportunity to work with the Emmes Group, and Martin Schroeder, EVP & Managing Director,” said Chris Bridges, President. “Mr. Schroeder and his colleagues at the Emmes Group have been responsible for helping to build cell therapy assets and developing and executing the business initiatives and licensing strategies for many biotech and pharmaceutical initiatives.” Mr. Bridges further stated.

About Applied BioSciences Corp.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to multiple International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and pet industries.

About Trace Analytics Inc.

Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology. The focus of the team is to ensure compliance with public safety standards andend user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com.

About Emmes Group

The Emmes Group is a strategy consulting and market research organization supporting firms engaged in the technology and healthcare industries. Our partners have over 50 years of combined experience. We work in partnership with our clients to increase profits and build lasting economic value. Our expertise spans a number of key areas, including: Strategy Consulting, Partnerships, Mergers & Acquisitions, Strategic Marketing, Market Research & Modeling, Business Development, Technology Licensing, Corporate Financing and, Venture Capital Due Diligence. http://www.emmesgroup.com.

Contact

Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:

www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:

Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

$APPB Applied Biosciences Announces Partnership with Boxing Heavyweight Champion Shannon Briggs $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM at 10:38 AM on Wednesday, March 20th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Signed a partnership agreement with Shannon “the Cannon” Briggs, the former heavyweight boxing champion and world record-holder for the most first round knockouts
  • Briggs and the Company will work together to formulate a line of athlete-focused cannabidiol (“CBD”) based health and wellness supplements to enhance training and recovery under the “Champ Organics” brand.

LOS ANGELES, March 20, 2019 (GLOBE NEWSWIRE) — Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and pet health industries, announced that has signed a partnership agreement with Shannon “the Cannon” Briggs, the former heavyweight boxing champion and world record-holder for the most first round knockouts. 

Through this new partnership, Briggs and the Company will work together to formulate a line of athlete-focused cannabidiol (“CBD”) based health and wellness supplements to enhance training and recovery under the “Champ Organics” brand.

Additionally, Briggs and the Company will collaborate on an awareness campaign to help educate athletes around the world about the potential benefits of using CBD for pain management, relaxation, decreasing anxiety and improving sleep quality.  Briggs hopes to educate the public on the potential benefits of using CBD to help decrease dependence on opioids.

“I have partnered with Applied BioSciences to develop and market Champ Organics because their products are made with the highest quality ingredients and all-natural CBD.  I am a firm believer in the benefits that CBD delivers for joint pain and headaches. Since I have incorporated CBD to my daily supplements, I have been surprised by the positive impact it has had on my overall quality of life.”  commented Shannon Briggs

“Every day, roughly 130 Americans die from opioid overdoses1,” noted Briggs. “Meanwhile, a recent study2 in the Journal of the American Medical Association showed that in states where people could legally use cannabis, the number of filled opioid prescriptions dropped significantly, and there were lower rates of opioid overdose and death.”

“The all-natural formulations of Applied Biosciences’ Remedi CBD products attracted Briggs to our Company,” commented Chris Bridges, President and Director of Applied Biosciences. “Our Company’s aligned mission to end the country’s opioid epidemic was what made him choose Applied in the end.  This partnership will allow us to expand into a new vertical and additional distribution channels globally.”

1:https://www.cdc.gov/drugoverdose/epidemic/index.html

2:https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2676999

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

About Shannon Briggs
Born in Brooklyn, New York, Shannon “the Cannon” Briggs was an American professional boxer for 20 years, having twice won the title of world heavyweight champion, having held the lineal title from 1997 to 1998, and the World Boxing Organization title from 2006 to 2007.

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

$APPB Applied Biosciences Announces Record Revenue Increase of 560% from Q3 2018 $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM at 8:40 AM on Monday, March 18th, 2019
  • Q3 Revenue for the Company was $413,109, a 560% increase from Q3 2018 and a 744% increase from the previous quarter
  • Launched multiple new products and has expanded into the Beverage and Health / Wellness category with Remedi Spa and Remedi Beverage and Shot
  • Started initial Pharmacokinetic Safety Study with a leading firm in the Pet space
  • Begun discussions regarding Scientific Trials with two leading Universities specializing in Veterinarian Medicine

LOS ANGELES, March 18, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and analytics and pet health industries, announced that it has achieved a record revenue quarter with multiple milestones. The company has made strategic investments in select brands and companies believed to be innovators in the consumer space.  The investment remains on the balance sheet under Equity Investments, but the company has begun a strategic review of options for the remaining equity stake.

Q3 2019 Financial and Operating Highlights

  • Q3 Revenue for the Company was $413,109, a 560% increase from Q3 2018 and a 744% increase from the previous quarter
  • Launched multiple new products and has expanded into the Beverage and Health / Wellness category with Remedi Spa and Remedi Beverage and Shot
  • Started initial Pharmacokinetic Safety Study with a leading firm in the Pet space
  • Begun discussions regarding Scientific Trials with two leading Universities specializing in Veterinarian Medicine

“Applied BioSciences results in the third quarter mark a solid acceleration to a historical year in a dynamic and rapidly evolving space.  We look forward to updating the investor community on our milestones and continued progress.”  stated Chris Bridges, President of Applied BioSciences Corp.

Subsequent to Q3 2019

  • Received a $186,000 distribution from its investment in Juul Labs, Inc.
  • Announced the acquisition of Trace Analytics with over 65 years of combined experience in the the global testing market for Cannabis and Hemp
  • Added 3 PhDs and 5 scientists to its operational team
  • Launch the first Organic Human Quality Pet Treats under the HerbalPet brand
  • Added Dr. Xiang-Qun (Sean) Xie to its Scientific Advisory Board. Dr. Xie who has over 30 years of experience in the fields of Genomics, Cancer Research and has multiple patents that have been licensed to BioTech and Pharmaceutical companies. 

“Applied BioSciences continues to be at the forefront of the evolving consumer and testing market, using organically grown plants, without pesticides or herbicides as our main ingredient.  As the company, continues to expand our product lines it is important to know that our products have been thoroughly tested by trusted labs in the industry for chemicals, pesticides and any harmful materials.  All our products are tested to ensure high-caliber and quality as well as overall safety.  We will now be able to test our products in an expedited fashion as well as from third-party labs and continue to provide the highest standard of testing results and safety protocols on all our products.” commented JJ Southard, Vice President of Applied BioSciences Corp.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis and hemp science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

CLIENT FEATURE: Applied Biosciences $APPB Rewards Shareholders with Dividend from JUUL Labs $JUUL $WMD.ca

Posted by AGORACOM at 10:17 AM on Monday, February 11th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png

OTCQB: APPB

  • Received a capital distribution of $186,000 from its investment in JUUL Labs, Inc. (JUUL).
  • Altria Group Inc. (NYSE: MO) invested $12.8bn (35%), valuing JUUL at $38 billion.
  • JUUL is one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years.
  • The global e-cig and vaporizer market is one of the fastest growing consumer markets, expected to reach $49 billion by the end of 2024
  • APPB recently acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company.
  • APPB also has a early stage investment in Hightimes Magazine
  • APPB: Market Cap of 20$M US with 10m shares outstanding

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp

CLIENT FEATURE: Applied Biosciences $APPB Investment in JUUL Labs Paying Dividends for Shareholders $HTIM $JUUL $WMD

Posted by AGORACOM at 10:19 AM on Wednesday, February 6th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL)
  • The investment remains on the balance sheet under Equity Investments, the company has begun a strategic review of options for the remaining equity stake. 
  • Altria Group Inc. (NYSE: MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion.
  • APPB also recently acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company with proven revenues
  • Applied BioSciences early stage investment in Hightimes Magazine is valued at approximately $1.75 Million at assumed IPO Pricing of $11.00
  • APPB has a market cap of $15m US & 10m S/O

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp.